1 
Republic of the Philippines 
HOUSE OF REPRESENTATIVES 
Quezon City 
TWENTIETH CONGRESS 
First Regular Session  
House Bill No. _______ 
Introduced by Representative Richard I. Gomez, DPA 
EXPLANATORY NOTE 
Sports embody fairness, discipline, and respect for the rules of competition. These values 
are gravely undermined by the use of performance-enhancing drugs, which endanger the health of 
athletes and provide an artificial and unjust advantage over those who compete clean. Substances 
used for doping can cause serious physical and psychological harm, including organ damage, 
hormonal imbalance, and aggression, while also eroding the very foundation of equal competition. 
Despite clear prohibitions, over the years, doping controversies have continued to cast a 
shadow over sports. One of the most notable incidents was the 1998 Tour de France scandal, which 
exposed the extent of drug use in professional cycling and emphasized the urgent need for stronger 
regulation. This global crisis paved the way for the establishment of the World Anti-Doping 
Agency (WADA) in 1999 to serve as the international body overseeing compliance with anti-
doping rules. 
More recently, on January 26, 2025, WADA issued a warning to the Philippines for alleged 
lapses in meeting international anti-doping obligations. Such a finding places the country at risk 
of sanctions, including possible exclusion from international competitions, a development that 
would endanger the opportunities of Filipino athletes and diminish the nation’s standing in the 
global sporting community. 
Performance-enhancing substances pose grave health risks, including organ damage, 
hormonal disorders, and psychological effects. Beyond the danger to individual athletes, doping 
distorts the level playing field that is fundamental to any sporting contest. It allows artificial 
advantage over athletes who compete honestly and deprives the public of genuine displays of 
human ability and determination. 
September 1, 2025
3:22 pm
4241


2 
The fight against doping is not only a matter of fairness but also of responsibility to society. 
Athletes, often seen as role models, influence young people to aspire to greatness through 
dedication and hard work. If the use of banned substances becomes associated with success, the 
harm extends far beyond the sports arena and into communities where young aspiring athletes may 
be encouraged to risk their health in pursuit of victory. 
Recognizing these challenges, many nations have strengthened their anti-doping 
institutions to align with global standards set by WADA. The Philippines must likewise adopt a 
comprehensive and independent anti-doping framework to ensure that its athletes remain eligible 
for international competition and that Philippine sports continue to embody the values of fairness, 
safety, and integrity. 
This proposed measure seeks to establish the Philippine National Anti-Doping 
Organization as the lead body mandated to implement the national anti-doping policy. The 
organization will be tasked to oversee testing programs, monitor compliance with international 
rules, and enforce sanctions for violations. Adequate funding will also be provided to sustain its 
operations and ensure consistency with global anti-doping protocols. 
Through this legislation, the Philippines affirms its commitment to protecting the health 
and welfare of athletes, safeguarding the integrity of competition, and ensuring that the country 
continues to take part honorably in international sports. 
In view of the foregoing, the immediate approval of this measure is earnestly sought. 
RICHARD I. GOMEZ, DPA 


3 
Republic of the Philippines 
HOUSE OF REPRESENTATIVES 
Quezon City 
TWENTIETH CONGRESS 
First Regular Session  
House Bill No. _______ 
Introduced by Representative Richard I. Gomez, DPA 
AN ACT 
PROVIDING FOR A NATIONAL ANTI-DOPING POLICY IN SPORTS, 
ESTABLISHING FOR THE PURPOSE THE PHILIPPINE NATIONAL ANTI-DOPING 
ORGANIZATION, AND APPROPRIATING FUNDS THEREFOR 
Be it enacted by the Senate and House of Representatives of the Philippines in Congress 
assembled: 
SECTION 1. Short Title. – This Act shall be known as the “Anti-Doping in Sports 
Act.” 
SEC. 2. Declaration of Policy.  — It is the policy of the State to give priority to education, 
science and technology, arts, culture, and sports to foster patriotism and nationalism, accelerate 
social progress, and promote total human liberation and development. 
Further, the State shall promote physical education and encourage sports programs, league 
competitions, and amateur sports, including training for international competitions, to foster self-
discipline, teamwork, and excellence for the development of a healthy and alert citizenry. 
To this end, the State shall promote and support the eradication of doping in sports in the 
country, in compliance with its obligations under the 2003 Copenhagen Declaration on Anti-
Doping in Sport, the 2005 United Nations Educational, Scientific and Cultural Organization 
International Convention Against Doping in Sport, the 2010 Ratification by the Philippines of the 
International Convention Against Doping in Sports, the World Anti-Doping Code, World Anti-
Doping Agency (WADA) International Standards, and the full representation and participation of 
the Philippines in the 2006 Southeast Asia Regional Anti-Doping Organization- the regional body 
responsible for implementing WADA doping controls and anti-doping education in the Southeast 
4241


4 
Asian region, with the end in view of protecting the health of athletes from potentially harmful 
doping substances and practices, and preserving the fundamental values of fairness, commitment, 
integrity, and equal opportunities in sport. 
 
SEC. 3. Definition of Terms. – As used in this Act: 
 
(a) Accredited laboratory refers to a laboratory accredited or approved by the WADA to 
test samples for the presence of prohibited substances or the use of prohibited methods in 
accordance with international standards; 
 
(b) Administration refers to providing, supplying, supervising, facilitating, or otherwise 
participating in the use or attempted use by another person of a prohibited substance or prohibited 
method: Provided, however, That this definition shall not include the actions of bona fide medical 
personnel involving a prohibited substance or prohibited method used for genuine and legal 
therapeutic purposes or other acceptable justification and shall not include actions involving 
prohibited substances which are not prohibited in out-of-competition testing, unless the 
circumstances as a whole demonstrate that such prohibited substances are not intended for genuine 
and legal therapeutic purposes or are intended to enhance sport performance; 
 
 
(c) Adverse analytical finding refers to a report from a WADA-accredited laboratory or 
other WADA-approved laboratory that, consistent with the International Standard for 
Laboratories, establishes in a sample the presence of a prohibited substance or its metabolites or 
markers or evidence of the use of a prohibited method; 
 
 
(d) Anti-doping activities refer to anti-doping education and information, test distribution 
planning, maintenance of a registered testing pool, managing Athlete Biological Passports, 
conducting testing, organizing analysis of samples, gathering of intelligence and conduct of 
investigations, processing of Therapeutic Use Exemption (TUE) applications, results management, 
monitoring and enforcing compliance with any consequences imposed, and all other activities 
related to anti-doping to be carried out by or on behalf of an Anti-Doping Organization, as set out 
in 
the 
World 
Anti-Doping 
Code 
or 
the 
international 
standards; 
 
 
(e) Anti-doping organization refers to the WADA or a signatory that is responsible for 
adopting rules for initiating, implementing, or enforcing any part of the doping control process, 
including the International Olympic Committee, the International Paralympic Committee, other 
major event organizations that conduct testing at their events, international federations, and 
national anti-doping organizations; 
 


5 
(f) Anti-doping rules refer to the regulations on anti-doping, including regulations under 
this Act, the World Anti-Doping Code, the Convention, and their amendments; 
 
(g) Anti-doping rule violations refer to the circumstances, acts, or conduct specified in 
Section 15 of this Act; 
 
(h) Appeal panel refers to the National Anti-Doping Appeal Panel created under Section 
24 of this Act; 
 
 
(i) Athlete Biological Passport refers to the program and methods of gathering and collating 
data as described in the International Standard for Testing and Investigations and the International 
Standard for Laboratories; 
 
 
(j) Athletes refer to any person, including athletes with disability, who compete in sports 
at the international level as defined by each international federation or the national level as 
determined by each National Sports Association (NSA), including any person in the Registered 
Testing Pool who is otherwise subject to the jurisdiction of this Act; 
 
 
(k) Athlete support personnel refers to a coach, trainer, manager, agent, team staff, official, 
medical or paramedical personnel, parent, or any other person working with, treating, or assisting 
an athlete participating in or preparing for a sports competition; 
 
 
(l) Board refers to the Philippine National Anti-Doping Organization (PHINADO) Board 
established under Section 12 of this Act; 
 
 
(m) Competition refers to a single race, match, game, or singular sport contest; 
 
 
(n) Convention refers to the United Nations Educational Scientific and Cultural 
Organization Convention Against Doping in Sport, adopted by the 33rd Session of the United 
Nations Educational Scientific and Cultural Organization General Conference on 19th October 
2005, including any and all amendments adopted by the States Parties to the Convention and the 
Conference of Parties to the International Convention against Doping in Sport; 
 
 
(o) Court of Arbitration for Sports refers to an international body established in 1984 to 
settle disputes related to sport through arbitration, whose headquarters are in Lausanne, 
Switzerland; 
 
 
(p) Disciplinary committee refers to the National Anti-Doping Disciplinary Committee 
established under Section 22 of this Act; 


6 
(q) Doping control refers to all steps and processes from test distribution planning through 
ultimate disposition of any appeal and the enforcement of consequences, including all steps and 
processes in between such as testing, investigations, whereabouts, TUEs, sample collection and 
handling, laboratory analysis, results management and investigations or proceedings relating to 
violations of Article 10.14 of the Code (Status During Ineligibility or Provisional Suspension); 
 
(r) Doping in sport refers to the occurrence of any anti-doping rule violations as defined 
under Section 15 of this Act; 
 
 
(s) Event refers to a series of individual competitions conducted together under one ruling 
body; 
 
 
(t) In-competition refers to the period commencing at 11:59 p.m. on the day before a 
competition in which the athlete is scheduled to participate through the end of such competition 
and the sample collection process related to such competition: Provided, however, That WADA 
may approve, for a particular sport, an alternative definition should an international federation 
provides a compelling justification that a different definition is necessary for its sport; upon such 
approval by WADA, the alternative definition shall be followed by all major event organizations 
for that particular sport; 
 
 
(u) International event refers to a sports competition where the International Olympic 
Committee, the International Paralympic Committee, an international federation, a major event 
organization, or another international sport organization is the ruling body for the event or appoints 
the technical officials for the event; 
 
(v) International federation refers to the international governing body for a particular sport; 
 
(w) International standard refers to a standard adopted by the WADA in support, in 
compliance with, and in the enforcement of the Code, and includes any technical documents issued 
in relation thereto. Compliance with an international standard (as opposed to another alternative 
standard, practice, or procedure) shall be sufficient to conclude that the procedures addressed by 
the international standard were performed properly; 
 
(x) National Anti-Doping Organization refers to the entity designated by each country as 
possessing the primary authority and responsibility to adopt and implement anti-doping rules, 
direct the collection of samples, manage test results, and conduct results management at the 
national level; 
 
(y) National event refers to a sports event or competition involving international or 
national-level athletes that is not an international event; 


7 
(z) National level athlete refers to athletes who compete in sport at the national level, as 
defined by each, consistent with the International Standard for Testing and Investigations. In the 
Philippines, 
national-level 
athletes 
are 
defined 
as 
those 
who: 
 
(i) Participate in the national leagues, events, or competitions organized by their NSA or 
by any sports organization or club; 
 
(ii). Are affiliated with a federation, national league, sports organization or club in the 
Philippines; 
 
(iii) Participate in competitions of events organized by schools, colleges, other institutions, 
and other intercollegiate events; or 
 
(iv) Participate in professional sports; 
 
 
(aa) National Sports Associations refer to an umbrella body organized for their respective 
sports in the Philippines and affiliated with their respective international federations, which are 
recognized by the International Olympic Committee responsible for Olympic, non-Olympic, 
Paralympic sports, or all sports disciplines; 
 
(bb) Out-of-competition testing refers to the sample collection during any period other than 
the period specified for in-competition testing; 
 
 
(cc) Philippine National Anti-Doping Organization or PHINADO refers to a body 
corporate created under Section 6 of this Act, which shall have the primary authority and 
responsibility to adopt and implement all anti-doping activities in the Philippines; 
 
(dd) Possession refers to the actual, physical possession, or the constructive possession 
which shall be found only if the person has exclusive control or intends to exercise control over 
the prohibited substance or prohibited method or the premises in which a prohibited substance or 
prohibited method exists: Provided, however, That if the person does not have exclusive control 
over the prohibited substance or prohibited method or the premises in which a prohibited substance 
or prohibited method exists, constructive possession shall only be found if the person knew about 
the presence of the prohibited substance or prohibited method and intended to exercise control 
over it: Provided, however, That there shall be no anti-doping rule violation based solely on 
possession if, prior to receiving notification of any kind that the person has committed an anti-
doping rule violation, the person has taken concrete action demonstrating that the person never 
intended to have possession and has renounced possession by explicitly declaring it to an anti-
doping organization. Notwithstanding anything to the contrary in this definition, the purchase, 


8 
including by any electronic or other means, of a prohibited substance or prohibited method 
constitutes possession by the person who makes the purchase; 
 
(ee) The prohibited list refers to the list provided by the World Anti-Doping Code, 
identifying the prohibited substances and prohibited methods; 
 
 
(ff) Prohibited method refers to any method so described on the Prohibited List; 
 
(gg) Prohibited substance refers to any substance, or class of substances, so described on 
the Prohibited List; 
 
(hh) Registered testing pool refers to the pool of highest-priority athletes established 
separately at the international level by International Federations and at the national level by 
National Anti-Doping Organizations, who are subject to focused In-Competition and Out-of-
Competition Testing as part of that International Federation’s or National Anti-Doping 
Organization’s test distribution plan and therefore are required to provide whereabouts information 
as provided in Article 5.5 of the Code (Athlete Whereabouts Information) and the International 
Standard for Testing and Investigations; 
 
(ii) Sample or specimen refers to any biological material collected for the purposes of 
doping control; 
 
(jj) Tampering refers to intentional conduct that subverts the Doping Control process but 
which would not otherwise be included in the definition of prohibited methods. Tampering shall 
include offering or accepting a bribe to perform or fail to perform an act, preventing the collection 
of a sample, affecting or making impossible the analysis of a sample, falsifying documents 
submitted to an Anti-Doping Organization from witnesses, committing any other fraudulent act 
upon the Anti-Doping Organization or hearing body to affect results management or the imposition 
of consequences, and any other similar intentional interference or attempted interference with any 
aspect of doping control or TUE committee or hearing panel, procuring false testimony in 
furtherance of any of the foregoing; 
 
(kk) Testing refers to the parts of the doping control process involving test distribution 
planning, sample collection, sample handling, and sample transport to the laboratory; 
 
(ll) Therapeutic use exemption allows an athlete with a medical condition to use a 
prohibited substance or prohibited method, but only if the conditions set out in Article 4.4 of the 
Code (Therapeutic Use Exemption) and the International Standard for Therapeutic Use 
Exemptions are met; 


9 
(mm) Trafficking refers to selling, giving, transporting, sending, delivering or distributing, 
or possessing for any such purpose, a prohibited substance or prohibited method, either physically 
or by any electronic or other means, by an athlete, athlete support person or any other person 
subject to the authority of an anti-doping organization to any third party: Provided, however, That 
this definition shall not include the actions of “bona fide” medical personnel involving a prohibited 
substance used for genuine and legal therapeutic purposes or other acceptable justification, and 
shall not include actions involving prohibited substances which are not prohibited in out-of-
competition testing unless the circumstances as a whole demonstrate such purposes or are intended 
to enhance sport performance; 
 
(nn) Use refers to the utilization, application, ingestion, injection, or consumption by any 
means of any prohibited substance or prohibited method; 
 
(oo) World Anti-Doping Agency refers to the sports body set up for the purposes of 
coordinating anti-doping activities worldwide; and 
 
(pp) World Anti-Doping Code, herein referred to as “Code,” refers to the core document 
that harmonizes anti-doping policies, rules, and regulations within sports organizations and among 
public authorities around the world. 
 
 
SEC. 4. Coverage. – The provisions of this Act shall apply to the following: 
 
(a) PHINADO; 
(b) International-level and National Level Athletes; 
(c) Athlete Support Personnel; 
(d) NSA; and 
(e) Other sports organizations, sports associations, and sports clubs. 
 
 
SEC. 5. Prohibition of Doping in Sport. – Athlete, athlete support personnel, and other 
persons covered by this Act shall: 
 
(a) Not engage in doping in sport; 
(b) Not conceal or fail to disclose any occurrence of any Anti-Doping Rule Violation as 
specified in this Act or by the Code; 
(c) Participate in a sport competition at all levels with the highest standards of integrity and 
ethics and in accordance with the provisions of this Act and the rules and regulations made 
thereunder; 
(d) Accept the anti-doping rules as a condition of such participation or involvement and be 
bound by the provisions of this Act and the rules and regulations made thereunder; 


10 
(e) Be responsible for knowing what constitutes Anti-Doping Rule Violations and the 
restrictions on the use of prohibited substances and the prohibited methods which are included in 
the Prohibited List; and 
(f) Bear any other responsibility as specified in the Code and the anti-doping rules. 
 
SEC. 6. Establishment of the Philippine National Anti-Doping Organization. – There is 
hereby established a body corporate known as the Philippine National Anti-Doping Organization, 
herein referred to as the PHINADO, designated by the Republic of the Philippines as possessing 
the primary authority and responsibility to adopt and implement anti-doping rules, direct the 
collection of samples, manage test results, and conduct results management at the national level. 
 
The PHINADO shall be established as an attached agency to the Philippine Sports 
Commission (PSC) for budgetary purposes, with its own budget separate from the PSC: Provided, 
however, that the PHINADO shall enjoy autonomy and independence in its operations, decisions, 
and activities. 
 
 
SEC. 7. Powers and Functions of the PHINADO. – In addition to the obligations of 
National Anti-Doping Organizations indicated in the Code, the PHINADO shall: 
 
(a) Adopt and implement anti-doping rules, regulations, and policies that conform to 
international obligations and commitments for promoting, coordinating, and monitoring the 
doping control program in sports to ensure doping-free sport; 
 
(b) Implement the United Nations Educational, Scientific, and Cultural Organization 
Convention Against Doping in Sport, herein referred to as the “Convention”, the Code, and other 
rules and regulations in accordance with this Act; 
 
(c) Develop a national strategy to address doping in sport in collaboration with the PSC, 
government agencies, and the private sector; 
 
(d) Plan, coordinate, implement, and monitor anti-doping activities in the country, 
including the collection of samples, managing test results, and conducting results management in 
all sports, sport associations, sport organizations, and sport clubs at the national level; 
 
(e) Enter into contracts and acquire movable and immovable property; 
 
(f) Promote anti-doping research in the field of prohibited substances and methods and 
doping practices in sport; 
 


11 
(g) Establish a program to support research and training in methods of detecting the use of 
performance-enhancing drugs by athletes; 
 
(h) Provide information to athletes, athlete support personnel, and other stakeholders on 
the updated list of prohibited substances as published by the WADA, including the procedures for, 
and developments concerning the collection and testing of samples in accordance with the Code 
and any standards developed by WADA; 
 
(i) Maintain data of all prohibited substances and prohibited methods in accordance with 
the directions of the WADA; 
 
(j) Select athletes who shall be requested to provide samples for testing when necessary; 
 
(k) Collect samples from athletes in accordance with approved guidelines and International 
Standards and secure the safe transit of samples to laboratories accredited by WADA for testing; 
 
(l) Conduct an investigation for purposes of determining possible violations of this Act and 
pursuant thereto, the PHINADO may invite witnesses to testify and direct them to bring or produce 
related documents as evidence. In case of non-compliance, the PHINADO may seek judicial 
assistance to compel attendance and compliance with its directives or request the court to exercise 
its contempt power to compel compliance; 
 
(m) 
Conduct 
results 
management 
of 
any 
Anti-Doping 
Rule 
Violation; 
 
(n) Undertake steps aimed at ensuring that the Government and the Philippine Olympic 
Committee (POC) comply with international agreements and other arrangements to which the 
Philippines is a party concerning the use of drugs and doping in sport; 
 
(o) Enforce anti-doping rules by exercising authority over athletes, athlete support 
personnel, and other persons, including NSAs and other sports organizations; 
 
(p) Coordinate and cooperate with the WADA, Other Anti-Doping Organizations, NSAs, 
and International Associations; 
 
(q) Facilitate and share information relating to the use of prohibited substances and 
prohibited methods, doping practices, or any Anti-Doping Rule Violation between sports bodies, 
officials conducting sports competitions or events, other anti-doping organizations and agencies; 
 
(r) Use only WADA-accredited laboratories or laboratories otherwise approved by WADA 
for analysis of samples and other required specimens; 


12 
(s) Maintain the Whereabouts Register and a Registered Testing Pool in accordance with 
the Code and International Standard for Testing and Investigations; 
 
(t) Prosecute anti-doping offenses; 
 
(u) Oversee all activities of the Therapeutic Use Exemptions Committee (TUEC); 
 
(v) Establish a code of conduct for officers and employees of the PHINADO and for such 
other persons or agencies engaged by the organization; 
 
(w) Undertake any other activity specified by regulations of the Board that may be 
expedient 
for 
fulfilling 
the 
objective 
of 
eliminating 
doping 
in 
sport; 
 
(x) Submit annual report to the Office of the President and both Houses of Congress; and 
 
(y) Implement the provisions of this Act. 
 
In the performance of its functions, the PHINADO shall address the needs of minors, 
protected persons, persons with disabilities or other persons with special needs, and ensure that the 
rights of everyone involved in the doping control procedures are respected. 
 
SEC. 8. Organizational Structure. – The PHINADO shall be headed by a Director General 
and shall be assisted by a Deputy Director General. The Human Resource complement of the 
PHINADO 
shall 
be 
organized 
and 
set 
up 
by 
the 
Director 
General. 
 
The Director General shall determine the organizational structure and staffing pattern of 
the PHINADO in accordance with the revised compensation and position classification system, 
subject to the evaluation and approval of the Department of Budget and Management (DBM), and 
in accordance with the civil service laws, rules, and regulations, and other pertinent laws. 
 
SEC. 9. The Director General. – The Director General shall be appointed by the President 
of the Philippines, from among persons of integrity and outstanding ability with an extensive 
background 
in 
sports, 
sports 
medicine, 
or 
sciences 
and 
other 
related 
fields. 
 
The Director General shall hold office on a full-time basis for a period of five (5) years, 
which term may be renewed, at the pleasure of the President. The Director General shall be 
responsible for the execution of the powers and functions of the PHINADO as prescribed under 
this Act, and shall have administrative control over the officers and other staff of the PHINADO. 
 
 
In the event of the occurrence of a vacancy in the office of the Director General by reason 


13 
of death, resignation, or continued disability to discharge the office, the Board may appoint any 
other person to discharge the functions of the Director General until a new Director General is 
appointed by the President. 
 
 
The Director General may relinquish the office by submitting in writing to the President of 
the Philippines a notice of not less than three (3) months before the effectivity date of resignation: 
Provided, That such resignation shall be effective from the date when it is accepted by the 
President. 
 
 
SEC. 10. The Deputy Director General. – The Deputy Director General shall be appointed 
by the Board to assist the Director General in managing and overseeing PHINADO’s anti-doping 
program, and to ensure strict adherence to the Code and international standards. The Deputy 
Director General shall actively engage with governmental agencies, NSAs, affiliated 
organizations, and non-government stakeholders to maintain effective anti-doping operations. 
 
 
SEC. 11. Employment of other officers and employees. – The Director General may 
appoint such officers and employees, subject to the rules and regulations of the Civil Service 
Commission and the DBM, upon such terms and conditions of service as it may consider necessary 
for the proper performance of its functions. 
 
A person shall be qualified to be employed by the PHINADO if such person was not a 
member or official of a national sports body for at least two (2) years immediately preceding the 
appointment. 
 
SEC. 12. Establishment of the PHINADO Board. – For purposes of this Act, the 
PHINADO Board is hereby established and shall be composed of the following: 
 
(a) Chairperson of the PSC as Chairperson; 
 
(b) Secretary of the Department of Science and Technology; 
 
(c) Secretary of the Department of Health (DOH); 
 
(d) Secretary of the Department of Education (DepED); 
 
(e) Chairperson of Commission on Higher Education (CHED); 
 
(f) President of the Games and Amusement Board (GAB); 
 
(g) President of the POC; 


14 
 
(h) President of the National Paralympic Committee; and 
 
(i) Three (3) representatives distinguished in the field of law, sports 
medicine, and sports science. 
 
The members of the Board from the government may designate their permanent authorized 
representatives. 
 
Within thirty (30) days from the effectivity, the members of the Board from the private 
sector shall be appointed by the President of the Philippines from a list of three nominees submitted 
by the members of the Board. To ensure their independence, members of the private sector shall 
not be appointed if that person: 
 
(a) Is a member of or an official of an NSA; 
 
(b) Is employed by or is associated with any person who supplies goods or services to the 
PHINADO or whose spouse or family member is so employed or associated therein; or 
 
(c) Is an athlete, athlete support personnel, or an official of a sports organization, sports 
club, or sports federation. 
 
 
Members representing the private sector of the Board shall serve for a term of three (3) 
years. In the event of the occurrence of a vacancy in the office of the Chairperson or Members of 
the Board by reason of death, resignation, retirement or when the Chairperson or Member is unable 
to discharge the functions owing to absence, illness or any other cause, the Board may assign 
temporarily any member of the Board for the period of vacancy, and such person shall discharge 
the functions of the Chairperson or Member, as the case may be, until a new Chairperson or 
Member, is appointed in accordance with the provisions of this Act to fill such vacancy, enters 
upon his office, or until the date on which the Chairperson or Member resumes duties of his office. 
 
 
SEC. 13. Powers and Functions of the PHINADO Board. – The Board shall: 
 
 
(a) Ensure implementation of the international obligations and commitments and monitor 
the compliance thereof; 
 
(b) Advise the President of the Philippines and the PSC Chairperson on matters relating to the 
regulations on anti-doping in sports and international obligations and commitments; 


15 
 
 
(c) Determine the date, time, venue, and quorum for the meetings as well as the procedure 
for transaction of business; 
 
 
(d) Establish such Committees as well as to appoint their members, necessary or expedient 
to assist PHINADO in the performance of its functions under this Act: Provided, That the 
Committees or Panels established under this Act may adopt and regulate their own internal rules 
of procedures consistent with this Act; 
 
(e) Oversee the processes of the different Committees created under this Act; 
 
(f) Control, supervise, and administer the assets of the PHINADO in such manner as best 
promotes the purpose for which the PHINADO is established; 
 
 
(g) Determine the provisions to be made for capital and recurrent expenditure and the 
reserves of the PHINADO; 
 
 
(h) Receive any grants, gifts, donations, or endowments and make legitimate disbursements 
therefrom; 
 
(i) Open such bank accounts for the funds of the PHINADO as may be necessary; 
 
 
(j) Lay down policy guidelines for operations and management of all funds collected by 
the PHINADO; 
 
 
(k) Oversee the activities of the PHINADO and require the PHINADO to submit 
information and reports relating to its operation; 
 
(l) Enter into associations with other bodies or organizations within and outside the 
Philippines as the PHINADO may consider desirable or appropriate in furtherance of the purpose 
for which the PHINADO is established; 
 
 
(m) Make regulations not inconsistent with any provision of this Act, the Code, 
Conventions, and international standards; and 
 
 
(n) Perform all such other acts or undertake any activity as may be incidental or conducive 
to the attainment or fulfillment of any of the functions of the PHINADO under this Act. 
 
 
SEC. 14. Meetings of the Board. – The Board shall meet at such times and places, and 
shall observe such procedure with regard to the transaction of business at its meetings, including 


16 
the quorum at such meetings, as may be provided by regulations made by the Board. Every 
decision of the Board shall be on the basis of a simple majority of the total membership of the 
Board. 
 
 
SEC. 15. Anti-Doping Rule Violations. – Any of the following circumstances, acts, or 
conduct committed by an athlete, athlete support personnel, or any other person, shall constitute 
an anti-doping rule violation: 
 
(a) The presence of a prohibited substance or its metabolites or markers in an athlete’s 
bodily specimen; 
 
(b) The use or attempted use of any prohibited substance or a prohibited method, unless 
such use is exempted by the TUEC under Section 18 of this Act; 
 
 
(c) Refusing or failing without compelling justification to submit to sample collection after 
notification as authorized in applicable anti-doping rules or otherwise evading sample collection; 
 
 
(d) Whereabouts failures by an athlete committed under any of the following instances: 
 
 
 
(i). Filing failure wherein the athlete has failed to submit his whereabouts 
information before the required deadline or to update the same after a change in circumstances, or 
even if submitted on time, is incomplete, inaccurate, or insufficient information to locate him for 
testing; 
 
 
 
(ii). Missed test wherein the athlete has filed his whereabouts information but is not 
available at the location for testing; or 
 
(iii). Such other omissions or failures as specified under Article 2.4 of the Code 
(Whereabouts Failures by an Athlete). 
 
(e) Tampering, or attempting to tamper, with any part or process of doping control; 
 
 
(f) 
Possession 
of 
prohibited 
substances 
or 
prohibited 
methods; 
 
(g) Trafficking or attempted trafficking of any prohibited substance or prohibited method; 
 
 
(h) Administration or attempted administration of a prohibited substance or prohibited 
method to any athlete during in-competition or out-of-competition; 
 
 
(i) Assisting, encouraging, aiding, abetting, conspiring, covering up, or any other type of 


17 
complicity involving an anti-doping rule violation or any attempted anti-doping rule violation or 
violation of the prohibition against participation during ineligibility or provisional suspension; and 
 
 
(j) Discouraging or retaliating against reporting to authorities. 
 
 
All of the above-indicated anti-doping rule violations shall be interpreted and applied in 
accordance with Article 2 of the Code (Anti-Doping Rule Violations). 
 
SEC. 16. Consequences of Anti-Doping Rule Violations. – The consequences of Anti-
Doping Rule Violations by an individual athlete, athlete support personnel, or any other person 
covered under this Act may result in one or more of the following, as further detailed in Article 10 
of the Code: 
 
 
(a) Disqualification of results, with all consequences including forfeiture of medals, points, 
and prizes, in such manner as may be specified by the PHINADO; 
 
 
(b) Ineligibility to participate in any competition or event or other activity or funding, for 
such period and in such manner, as may be specified by the PHINADO; 
 
 
(c) Provisional suspension from participating in any competition or activity prior to the 
decision on appeal; 
 
 
(d) Imposition of financial sanction, including proportionate recovery of costs, for the 
training and other related expenses; and 
 
 
(e) Public disclosure and such other consequences as may be specified by the PHINADO. 
 
 
The consequences of anti-doping rule violations for team sports and any other persons 
covered under this Act shall be determined by the Board. 
 
 
SEC. 17. Conformity to Anti-Doping Rules. – Each NSA, sports association, sports 
organization, sports club, and sports federation shall require all athletes and athlete support 
personnel to agree to be bound by all anti-doping rules and PHINADO’s results management 
authority in conformity with the Code as a condition for such participation. 
 
 
An athlete or athlete support personnel who is not a minor shall be required to sign a 
conformity to the Anti-Doping Rules and submit the same to the PHINADO. In case of a minor, 
the parent/s or guardian shall sign such acceptance and submit the acceptance to the PHINADO. 
 
 
SEC. 18. Therapeutic Use Exemptions. – Any athlete with a medical condition, requiring 


18 
the use of a prohibited substance or prohibited method, may apply for a therapeutic use exemption, 
with the assistance of the athlete’s NSA, where necessary, to the TUEC established pursuant to 
Section 19 of this Act, for a therapeutic use exemption, in accordance with the provisions of this 
Act and the Anti-Doping Rules. 
 
 
SEC. 19. Therapeutic Use Exemptions Committee. – There shall be created a TUEC to 
consider applications for TUEs for athletes in accordance with the relevant provisions of this Act, 
the Code, and the International Standard for Therapeutic Use Exemptions (ISTUE). 
 
 
The TUEC shall be composed of five (5) independent medical experts, including the TUEC 
Chairperson, who shall be elected from among the members of the TUEC. 
 
 
The TUEC members must be medical doctors for not less than five (5) years of experience 
in the fields of clinical, sports and exercise medicine, psychiatry, para- sports, and with significant 
experience in the care and treatment of athletes: Provided, That the TUEC Chairperson must be a 
medical practitioner with seven (7) years of experience in the same fields of expertise. 
 
 
SEC. 20. Duties of the TUEC. – The TUEC shall: 
 
 
(a) Receive, review, reject, and approve applications for the grant of TUE by athletes who 
compete at the national level, and at the international level, if requested to do so by an international 
federation; 
 
 
(b) Review TUE issued by an international federation for compliance with the ISTUE for 
the purpose described in Article 4.4.3.2 of the Code (In case where the athlete does not already 
have a TUE granted by the NADO for the substance or method in question); 
 
 
(c) Refer to the WADA any TUE issued by an international federation which, in its view, 
does not meet the requirements of the ISTUE; 
 
 
(d) Notify the concerned athlete and sports association of the result of the TUE application; 
and 
 
 
(e) Perform any other functions that are conferred by this Act or the ISTUE.  
 
 
In the performance of its duties, the TUEC shall comply with the provisions of the 
following: 
 
 
(a) The Convention; 
(b) The Code; 


19 
(c) International Standard for Therapeutic Use Exemptions; 
(d) The Prohibited list; 
(e) The provisions of this Act; and 
(f) The PHINADO’s Anti-Doping Rules. 
 
 
Any person aggrieved by the decision of the TUEC may file an appeal to the Appeal Panel 
established under Section 24 of this Act. 
 
SEC. 21. Accredited WADA Laboratories. – A sample taken from an athlete shall be 
analyzed only at an accredited WADA laboratory or laboratory approved by WADA to detect 
prohibited substances and prohibited methods or as otherwise permitted by Article 6.2 of the Code 
(Purpose of Analysis of Samples and Data). A sample shall not be analyzed for any other purpose 
unless: 
 
 
(a) The athlete consents in writing; 
(b) Any means of identification is removed to ensure that the sample cannot be traced back 
to the athlete; and 
(c) The results of all tests shall be submitted to the PHINADO. 
 
 
SEC. 22. Disciplinary Committee. – There shall be established a Disciplinary Committee, 
which shall comply with the requirements found in the definition of Operational Independence in 
the Code and shall consist of: 
 
(a) A Chairperson who is a legal expert with not less than ten (10) years of experience as a 
legal practitioner; 
 
(b) Two (2) legal practitioners who have at least five (5) years of experience; and 
 
 
(c) Two (2) persons who have had previous experience in sports administration and sports 
medicine or related fields. 
 
 
The Chairperson and members of the Disciplinary Committee shall be appointed by the 
Board for a term of six (6) years and shall be eligible for reappointment for another term. The 
quorum for the conduct of the business of the Panel shall be three (3) members. 
 
 
SEC. 23. Duties and Jurisdiction of the Disciplinary Committee. – The Disciplinary 
Committee shall: 
 
(a) 
Receive, 
examine, 
and 
hear 
anti-doping 
rules 
violations; 
 


20 
(b) 
Conduct 
disciplinary 
hearing 
related 
to 
anti-doping 
rules 
violations; 
 
(c) Determine whether a violation of the Anti-Doping Rules has occurred; 
 
 
(d) Issue contempt orders and provide administrative penalties in the enforcement thereof 
to ensure compliance; 
 
 
(e) Impose sanctions and penalties for Anti-Doping Rules violations; and 
 
 
(f) Perform any other functions that are conferred or imposed on the Panel under this Act, 
the Code, or the International Standard for Results Management. 
 
 
In the exercise of jurisdiction and performance of duties, the Disciplinary Committee shall 
comply with the provisions of the following: 
 
 
(a) The Convention; 
(b) The Code; 
(c) International Standard for Results Management; 
(d) The Prohibited List; 
(e) The provisions of this Act; and 
(f) The PHINADO’s Anti-Doping Rules 
 
 
Anti-doping rules violations involving national level athletes, athlete support personnel, 
NSA’s and sports organizations, shall be resolved by the Disciplinary Committee at the first 
instance within a period of thirty (30) days, after the conduct of the hearing or submission of 
pleadings and subject to appeal to the Appeal Panel within fifteen (15) days from receipt of the 
decision of the Disciplinary Committee. Notwithstanding the aforementioned, the WADA’s 
deadline to appeal to the Appeal Panel shall be as specified in the Code. 
 
 
The Appeal Panel must resolve the matter within thirty (30) days from receipt of the entire 
records from the Disciplinary Committee. Appeal to the Court of Arbitration for Sport may also 
be filed by those parties with the right to appeal to the Court of Arbitration for Sport as specified 
in the Code, within fifteen (15) days from receipt of the decision of the Appeal Panel. 
Notwithstanding the aforementioned, the WADA’s appeal deadline to appeal to the Court of 
Arbitration for Sport shall be as specified in the Code. The decision of the Court of Arbitration for 
Sport shall be final and executory. 
 
 
Anti-doping rule violations arising from participation in an international event or involving 
international level athletes shall be resolved by the Disciplinary Committee at the first instance 
where PHINADO is the results management authority and may be appealed directly to the Court 


21 
of Arbitration for Sport by those parties with the right of appeal to the Court of Arbitration for 
Sport as specified in the Code. The decision of the Court of Arbitration for Sport is final and 
executory. 
 
 
All impositions of penalties and recommendations, however, shall be implemented by the 
PHINADO. 
 
 
No final decision by the Disciplinary Committee shall be quashed, reversed, modified, or 
held invalid by any court, arbitrator, tribunal, or other hearing body other than the Court of 
Arbitration for Sport for any reason, including for reason of any defect, irregularity, omission, or 
departure from the procedures set out in this Act. 
 
SEC. 24. Appeal Panel. – There shall be established an Appeal Panel for purposes of 
hearing the appeals filed pursuant to this Act, and it shall be composed of the following: 
 
 
(a) A Chairperson who is a member of the Philippine Bar with at least ten (10) years of 
legal practice; 
 
 
(b) Two (2) members who are members of the Philippine Bar with at least five (5) years of 
legal practice; and 
 
 
(c) Two (2) members who are registered medical practitioners with at least seven (7) years 
of experience. 
 
 
The Chairperson and other members of the Appeal Panel shall be appointed by the PSC for 
a term of five (5) years, and shall be eligible for reappointment for another five (5) years: Provided, 
that each member shall be eligible for reappointment. 
 
 
SEC. 25. Doping Control Process. – In the exercise of its powers, duties, and 
responsibilities, the PHINADO shall perform the following acts, subject to the Code and 
International Standards, existing laws, rules, and regulations: 
 
 
(a) Collect samples and testing. In accordance with the International Standards, the 
PHINADO may, randomly at its discretion or when it has reasons to believe that an athlete has 
committed an anti-doping rule violation, require such person to provide samples for doping 
control, in accordance with such procedure and in such manner, as may be specified by this Act; 
 
 
(b) Entry, search, and seizure. Where the PHINADO has reasons to believe that an athlete, 
athlete support personnel, or any other person covered by this Act has committed an anti-doping 


22 
rule violation, any person authorized by the PHINADO, after securing the appropriate search 
warrant, and in the presence of local police authorities, may: 
 
(i) enter and search any place, for the purpose of inspecting, examining, and 
obtaining evidence of any anti-doping rule violation that has been committed or is 
being committed; and 
 
(ii) seize any equipment, device, substance, record, register, document or other 
material object, as evidence of such Anti-Doping Rule Violation for purposes of 
prosecution or mitigation, or prevention of any anti-doping rule violation. 
 
(c) Result management process. After receiving an adverse analytical finding report from 
a WADA accredited laboratory showing presence of any prohibited substance or the use of any 
prohibited method in the sample of an athlete, the PHINADO shall carry out initial examination 
of the report and verify if TUE has been granted to such athlete in respect of such substance, in 
addition to carrying out any other review required by the International Standard for Results 
Management. 
 
 
The PHINADO shall take such action in such manner specified by the International 
Standard 
for 
Results 
Management 
following 
the 
initial 
review. 
 
 
SEC. 26. Registered Testing Pool. – The PHINADO shall establish a registered testing 
pool in accordance with the Code and the International Standard for Testing and Investigations. 
The PHINADO shall, in accordance with the Anti-Doping Rules, publish criteria for the inclusion 
of the name of an athlete in its registered testing pool. The PHINADO shall notify the concerned 
athlete, in writing, of the inclusion of his or her name in its registered testing pool, and shall also 
notify the athlete in writing when they are removed from the registered testing pool. 
 
 
SEC. 27. Data of Athletes and Maintenance of Database. – The PHINADO shall collect, 
use, and process the following personal data for the purposes of implementing the objectives of 
this 
Act 
and 
in 
accordance 
with 
applicable 
data 
privacy 
regulations: 
 
(a) List of anti-doping rule violations committed by an athlete under this Act or the Code 
and the details of such violation; 
(b) Medical history of the athlete; 
(c) Whereabouts information of the athlete; and 
(d) Any other personal data as it may deem necessary. 
 
 
The PHINADO may issue regulations to govern the procedure for the collection, usage, 
processing, and disclosure of personal data. It shall establish and maintain a database to record all 


23 
the sanctions imposed by the PHINADO, the Disciplinary Committee, the Appeal Panel, and such 
other details of the sanctions, in such manner as may be prescribed by regulations. 
 
SEC. 28. Duties and Responsibilities of Athletes, Athlete Support Personnel, NSAs, 
sports organizations, sports associations, and sports clubs. – The athletes, athlete support 
personnel, NSAs, sports organizations, sports associations, and sports clubs shall: 
 
(a) Respect PHINADO’s TUECs, Disciplinary Committee ,and Appeal Panel’s autonomy 
and 
not 
to 
interfere 
with 
its 
operational 
decisions 
or 
activities; 
 
 
(b) Require clubs and other similar bodies under its authority to report to PHINADO any 
information related to an anti-doping rule violation and to cooperate with investigations conducted 
by 
any 
Anti-Doping 
Organization 
with 
authority 
to 
conduct 
the 
investigation; 
 
(c) Cooperate with the conduct of operation of an investigation, including the establishment 
of a doping test room at an event sponsored by it or subordinated bodies; 
 
(d) Take appropriate information delivery and implement support measures towards 
athletes who are part of the PHINADO’s Registered Testing Pool, such as ensuring that them to 
submit 
whereabouts 
filing 
in 
the 
Registered 
Testing 
Pool; 
 
(e) Report to PHINADO, and to ensure the appropriate enforcement of sanctions, penalties 
and other consequences of, all potential anti-doping rule violations within its jurisdiction including 
investigation into whether athlete support personnel or other persons may have been involved in 
each case of doping, as well as to implement automatic investigation into anti- doping rule 
violations related to a minor; 
 
(f) Comply with anti-doping rules; and 
 
(g) Assist PHINADO in formulating rules, regulations, and policies to promote 
anti-doping. 
 
 
Lack of knowledge about anti-doping regulations and the substances and methods, which 
have been included on the Prohibited List, shall not be a justification for non-compliance with any 
of the provisions provided for under this Act. 
 
NSAs shall obey the provisions of this Act and PHINADO rules in case of imposition of 
sanctions against an athlete, athlete support personnel, or other person under the NSA’s 
jurisdiction. Non-execution of obligations stipulated herein by the NSA shall be considered a 
violation of this Act. 


24 
SEC. 29. Administrative Sanctions and Penalties. – Where any athlete has been found to 
have committed any anti-doping rule violation as defined under Section 15 of this Act, the 
consequences of such violation as provided in Section 16 hereof as well as the PHINADO Rules 
shall apply for the purpose of determining and imposing the appropriate consequences: Provided, 
That athlete support personnel, coaches, trainers, or any other person who connive, conspire, assist, 
aid, abet, or cover-up any other type of complicity involving an anti-doping rule violation or any 
attempted Anti-doping rule violation shall also be subject to administrative sanctions and penalties 
under this Act and the PHINADO Rules. 
 
Where a medical professional is found to be in complicity with Anti-doping violations, the 
Disciplinary Committee shall endorse the violation to the Professional Regulatory Commission, 
which shall also impose, depending on the gravity of the violation, the penalty of suspension or 
revocation of the professional license. 
 
SEC. 30. Integration of Anti-Doping Policy into the Educational System. – The PSC, the 
DepEd, the CHED, the National Academy of Sports, in coordination with the PHINADO, shall 
ensure the integration of age-appropriate content pertaining to anti-doping into the physical 
education curriculum at all educational levels, both in public and private institutions. 
 
 
SEC. 31. Appropriations. – The amount necessary for the initial implementation of this 
Act shall be charged against the current year’s appropriations of the PSC. Thereafter, the funding 
for the continued implementation thereof shall be included in the annual General Appropriations 
Act. 
 
 
SEC. 32. Transitory Clause. – All property, assets, rights, liabilities, obligations, 
agreements, conveyances, deeds, leases, licenses, permits, exemptions, power of attorney, 
undertakings, securities and other arrangements existing at the commencement of this Act and 
vested in, acquired, incurred or entered into by or on behalf of the former PHI-NADO under the 
PSC, shall upon the commencement of this Act, be deemed to have vested in or to have been 
acquired, incurred or entered into by or on behalf of the PHINADO established under this Act to 
the same extent as they were enforceable by or against the former PHI-NADO before the 
commencement of this Act. 
 
A person who, immediately before the commencement of this Act, was an employee of 
former PHI-NADO shall, on the commencement of this Act, be deemed to be an employee of the 
PHINADO established under this Act. 
 
SEC. 33. Implementing Rules and Regulations. – The PHINADO shall, in consultation 
with the PSC, DOH, GAB, NSAs, POC, CHED, DepEd, National Academy of Sports, and 
Philippine Regulation Commission, not later than thirty (30) days upon the effectivity of this Act, 


25 
promulgate the necessary rules and regulations for the effective implementation of this Act: 
Provided, That failure to promulgate the rules and regulations shall not prevent the implementation 
of this Act upon its effectivity. 
 
 
SEC. 34. Separability Clause. – If any part or provision of this Act is held invalid or 
unconstitutional, the other provisions not affected thereby shall remain in full force and effect. 
 
SEC. 35. Repealing Clause. – All laws, executive orders, issuances, decrees, rules, and 
regulations inconsistent with or contrary to the provisions of this Act are deemed amended, 
modified, or repealed accordingly. 
 
SEC. 36. Effectivity. – This Act shall take effect fifteen (15) days after its publication in 
the Official Gazette or in a newspaper of general circulation. 
 
 
Approved,